Original Report
You have free access to this content
Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned
Article first published online: 19 JAN 2012
DOI: 10.1002/pds.2321
Copyright © 2012 John Wiley & Sons, Ltd.
Issue

Pharmacoepidemiology and Drug Safety
Supplement: The U.S. Food and Drug Administration's Mini-Sentinel Program
Volume 21, Issue Supplement S1, pages 82–89, January 2012
Additional Information
How to Cite
Carnahan, R. M. and Moores, K. G. (2012), Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned. Pharmacoepidem. Drug Safe., 21: 82–89. doi: 10.1002/pds.2321
Publication History
- Issue published online: 19 JAN 2012
- Article first published online: 19 JAN 2012
Funded by
- FDA. Grant Number: HHSF223200910006I
REFERENCES
- 1, , . Validity of pharmacoepidemiologic drug and diagnosis data . In Pharmacoepidemiology, Strom BL (ed.). John Wiley: Chichester, 2005; pp. 709–766.
- 2FDA Designated Medical Events (DME). Listing of DMEs is adapted from “Safety Reporting Requirements for Human Drug and Biological Products; Proposed Rule”. http://www.fda.gov/OHRMS/DOCKETS/98fr/03-5204.pdf (accessed 4 June, 2010).
- 3The Observational Medical Outcomes Partnership (OMOP). Health Outcomes of Interest. http://omop.fnih.org/HOI (accessed 4 June, 2010).
- 4. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: summary of findings and suggestions for future research. Pharmacoepidemiol Drug Saf 2012; 21(S1): 90–99.
- 5, , , et al. A systematic review of validated methods for identifying cerebrovascular accidents or transient ischemic attacks using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 100–128.
- 6, , , et al. A systematic review of validated methods for identifying congestive heart failure using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 129–140.
- 7, , , , , . A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 141–147.
- 8, , . A systematic review of validated methods for identifying ventricular arrhythmias using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 148–153.
- 9, , . A systematic review of validated methods for identifying venous thromboembolism using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 154–162.
- 10, , , . A systematic review of validated methods for identifying depression using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 163–173.
- 11, , , . A systematic review of validated methods for identifying suicide or suicidal ideation using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 174–182.
- 12, , , , . A systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 183–193.
- 13, , , . A systematic review of validated methods for identifying pancreatitis using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 194–202.
- 14, , , . A systematic review of validated methods for identifying lymphoma using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 203–212.
- 15, , . A systematic review of validated methods for identifying infection related to blood products or tissue grafts using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 213–221.
- 16, , . A systematic review of validated methods for identifying transfusion-related sepsis using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 222–229.
- 17, . A systematic review of validated methods for identifying transfusion-related ABO incompatibility reactions using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 230–235.
- 18, , , et al. A systematic review of validated methods for identifying erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 236–239.
- 19, , , et al. A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioedema, using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 241–248.
- 20, , , et al. A systematic review of validated methods for identifying hypersensitivity reactions other than anaphylaxis using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 249–256.
- 21, , , , , . A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 256–260.
- 22, , , , , . A systematic review of validated methods for identifying acute respiratory failure using administrative data. Pharmacoepidemiol Drug Saf 2012; 21(S1): 262–265.
- 23, , . Systematic evaluation of health outcome of interest definitions in observational studies and clinical definitions for the Observational Medical Outcomes Partnership: angioedema: report. http://omop.fnih.org/sites/default/files/RTI%20Angioedema%20Final%20Report%20110509.pdf (accessed 7 June, 2010).
- 24, , . Systematic literature review for evaluation of angioedema. Final report prepared for the Foundation of the National Institutes of Health via the Observational Medical Outcomes Partnership. http://omop.fnih.org/sites/default/files/UBC-OMOP%20Systematic%20Lit%20Review%20Angioedema%20Final%20Report%209-11-2009.pdf (accessed 7 June, 2010).
- 25, , . Systematic evaluation of health outcome of interest definitions in observational studies and clinical definitions for the Observational Medical Outcomes Partnership: acute renal failure: report. http://omop.fnih.org/sites/default/files/RTI%20Acute%20Renal%20Failure%20Final%20Report-110509.pdf (accessed 7 June, 2010).
- 26, , . Systematic literature review for evaluation of renal failure. Final report prepared for the Foundation of the National Institutes of Health via the Observational Medical Outcomes Partnership. http://omop.fnih.org/sites/default/files/UBC%20Systematic%20Lit%20Review%20Renal%20Failure%20Final%20Report%20OMOP%209-11-2009.pdf (accessed 7 June, 2010).

1099-1557/asset/PDS_left.gif?v=1&s=f962ae698249deba4dc56217f1bb95eac528fe4d)
1099-1557/asset/PDS_right.gif?v=1&s=44103455c6e4e28135198609bb6a426efee9a51c)